280 related articles for article (PubMed ID: 30558634)
1. Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease.
Lin R; Chen H; Shu W; Sun M; Fang L; Shi Y; Pang Z; Wu W; Liu Z
J Transl Med; 2018 Dec; 16(1):359. PubMed ID: 30558634
[TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
Frehn L; Jansen A; Bennek E; Mandic AD; Temizel I; Tischendorf S; Verdier J; Tacke F; Streetz K; Trautwein C; Sellge G
PLoS One; 2014; 9(9):e106750. PubMed ID: 25215528
[TBL] [Abstract][Full Text] [Related]
3. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin coating of faecal bacteria in inflammatory bowel disease.
van der Waaij LA; Kroese FG; Visser A; Nelis GF; Westerveld BD; Jansen PL; Hunter JO
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):669-74. PubMed ID: 15201580
[TBL] [Abstract][Full Text] [Related]
6. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease.
Masu Y; Kanazawa Y; Kakuta Y; Shimoyama Y; Onodera M; Naito T; Moroi R; Kuroha M; Kimura T; Shiga H; Kinouchi Y; Masamune A
Sci Rep; 2021 Aug; 11(1):16672. PubMed ID: 34404881
[TBL] [Abstract][Full Text] [Related]
8. Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease.
Kohoutova D; Drahosova M; Moravkova P; Rejchrt S; Bures J
BMC Gastroenterol; 2014 Dec; 14():190. PubMed ID: 25551469
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
Philipsen EK; Bondesen S; Andersen J; Larsen S
Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
[TBL] [Abstract][Full Text] [Related]
10. Decreased immunoglobulin A concentrations in feces, duodenum, and peripheral blood mononuclear cells of dogs with inflammatory bowel disease.
Maeda S; Ohno K; Uchida K; Nakashima K; Fukushima K; Tsukamoto A; Nakajima M; Fujino Y; Tsujimoto H
J Vet Intern Med; 2013; 27(1):47-55. PubMed ID: 23216572
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease.
Gouni-Berthold I; Baumeister B; Berthold HK; Schmidt C
Hepatogastroenterology; 1999; 46(27):1720-3. PubMed ID: 10430330
[TBL] [Abstract][Full Text] [Related]
12. Association of levels of antibodies from patients with inflammatory bowel disease with extracellular proteins of food and probiotic bacteria.
Hevia A; López P; Suárez A; Jacquot C; Urdaci MC; Margolles A; Sánchez B
Biomed Res Int; 2014; 2014():351204. PubMed ID: 24991549
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A.
Oriishi T; Sata M; Toyonaga A; Sasaki E; Tanikawa K
Gut; 1995 Jun; 36(6):891-6. PubMed ID: 7615279
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
16. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
18. Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease.
Jansen A; Mandić AD; Bennek E; Frehn L; Verdier J; Tebrügge I; Lutz H; Streetz K; Trautwein C; Sellge G
Scand J Gastroenterol; 2016 Dec; 51(12):1453-1461. PubMed ID: 27455092
[TBL] [Abstract][Full Text] [Related]
19. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]